Why Surface Treatment Determines Osseointegration Speed
When a dental implant is placed into bone, osseointegration — the direct structural and functional connection between living bone and the implant surface — does not begin immediately. The cascade that ultimately determines how quickly and how completely bone bonds to titanium is initiated within milliseconds of implant-blood contact, and the implant surface plays a decisive role in that cascade.
Three surface properties are most clinically relevant:
- Surface roughness (Ra): Measured in micrometers, Ra describes the average height of peaks and valleys across the surface. Moderate roughness in the Sa 1–2 µm range at the micro scale (and Ra 3–5 µm at the macro scale) has consistently shown superior bone-to-implant contact (BIC) values compared to smooth machined surfaces. Roughness increases surface area and provides mechanical interlocking points for osteoblast attachment and bone matrix deposition.
- Wettability (contact angle): A hydrophilic surface (contact angle <5°) allows blood to spread instantly and uniformly, accelerating fibrin clot formation and platelet activation. Hydrophobic surfaces (contact angle >60°) repel aqueous fluids, creating air pockets that delay the initial biological response. This single parameter can shift osseointegration kinetics by 2–3 weeks.
- Protein adsorption dynamics: The first proteins to adsorb onto the implant surface — primarily albumin, fibronectin, and vitronectin — create a conditioning layer that dictates subsequent cell behavior. Hydrophilic surfaces preferentially adsorb fibronectin and vitronectin, which contain RGD (Arg-Gly-Asp) domains recognized by osteoblast integrins, promoting adhesion and proliferation. Hydrophobic surfaces favor albumin adsorption, which is biologically inert and acts as a passivating layer that slows osteogenic response.
In vitro studies demonstrate that hydrophilic surfaces achieve 2–3 times greater fibronectin adsorption than equivalent hydrophobic surfaces within the first 60 seconds of blood contact — a critical window that sets the trajectory for the entire osseointegration cascade.
Surface-by-Surface Clinical Analysis
SLA — Sandblasted Large-grit Acid-etched (Straumann)
Introduced by Straumann in the 1990s, SLA established the gold standard for implant surface technology for nearly two decades. The process involves large-grit sandblasting (Al₂O₃ or corundum particles, 250–500 µm) to create macro-roughness, followed by dual-acid etching (HCl/H₂SO₄) to generate micro-roughness at the 1–4 µm scale. The result is a well-characterized surface with an average roughness of approximately 4 µm, outstanding mechanical interlocking geometry, and a titanium dioxide (TiO₂) passivation layer.
The clinical evidence base for SLA is enormous — thousands of clinical studies and 25+ years of survival data. The primary limitation is its hydrophobic nature: contact angles of 130–140° mean the surface temporarily repels blood during early wound healing, requiring the biological environment to "wet" the surface over time. Standard loading protocols of 6–8 weeks were originally established to compensate for this slower early-phase biological response.
SLActive — Hydrophilic SLA (Straumann)
SLActive retains the identical macro- and micro-topography of SLA but undergoes a critical post-processing step: after acid etching, the implant surface is rinsed in nitrogen-protected isotonic NaCl solution and stored in this solution until use. This process preserves a chemically active surface by preventing oxidation and hydrocarbon contamination. The result is a contact angle of essentially 0° — the surface is superhydrophilic and spreads blood instantly upon contact.
The biological consequences are profound. Clinical and histomorphometric studies demonstrate that SLActive accelerates early bone formation by approximately 2 weeks relative to SLA, with statistically significantly higher BIC values at 2 and 4 weeks post-placement. Resonance frequency analysis (RFA) studies show ISQ values that are not only higher at early time points but also remain more stable through the remodeling phase, suggesting a more robust and predictable osseointegration trajectory. The standard loading protocol for SLActive is 3–4 weeks, and its use in immediate loading protocols (where primary stability is confirmed) is well-documented.
Acqua — Hydrophilic Surface (Neodent)
Neodent's Acqua surface employs the same conceptual strategy as SLActive — combining a sandblast + acid etch topography with a post-processing hydrophilization step to achieve a low contact angle and enhanced early biological response. The Acqua surface is stored under controlled conditions to maintain surface activity, and clinical studies demonstrate osseointegration kinetics that are statistically comparable to SLActive in head-to-head comparisons.
Independent studies published in the International Journal of Oral & Maxillofacial Implants have shown Acqua implants achieving ISQ values of 70–75 at 4 weeks in standard bone (D2–D3), comparable to SLActive benchmarks. For dental practices purchasing at scale, Acqua provides the clinical performance characteristics of SLActive at a more cost-effective price point, particularly relevant when planning high-volume full-arch cases where per-unit economics matter.
NeoPoros — Nano-topography Surface (Neodent)
NeoPoros represents Neodent's nano-scale surface modification technology. In addition to the conventional micro-roughness created by sandblasting and acid etching, NeoPoros incorporates a secondary nanotopography layer — surface features at the 1–100 nm scale — through a controlled chemical deposition or anodization process. These nanoscale features are believed to directly interact with integrin receptors on osteoblast cell membranes, enhancing cell adhesion and differentiation independent of the macro-roughness geometry.
Preclinical data show NeoPoros achieving significantly higher BIC percentages in low-density bone models compared to conventional sandblasted-and-etched surfaces. The combination of micro and nano topography addresses two scales of biological interaction simultaneously, and is particularly relevant for implants placed in D3–D4 bone where every incremental improvement in early BIC has clinical significance for primary stability maintenance during healing.
TiUnite — Anodized Oxide Layer (Nobel Biocare)
Nobel Biocare's TiUnite surface takes a fundamentally different approach to surface modification. Rather than mechanical blasting and acid etching, TiUnite uses a micro-arc oxidation (anodization) process that forms a thick (10–15 µm), porous titanium dioxide layer that is phosphate-enriched. The resulting surface has an open, interconnected pore structure at the 1–10 µm scale with a chemically active titanium oxide composition that promotes direct apatite nucleation from biological fluids.
The phosphate incorporation in TiUnite's oxide layer is thought to promote hydroxyapatite precipitation at the implant surface early in healing, acting as a scaffold for mineralized bone matrix deposition. Long-term clinical data for TiUnite are extensive, particularly for the Nobel Active and Nobel Parallel CC implant systems, with 5–10 year survival rates consistently above 97% in favorable bone conditions.
Xpeed — UV-Photoactivated Surface (MegaGen)
MegaGen's Xpeed surface uses ultraviolet (UV) photofunctionalization as its hydrophilization mechanism. Standard sandblasted and acid-etched implant surfaces accumulate hydrocarbon contamination over time (a process called surface aging), gradually shifting from hydrophilic to hydrophobic character. UV irradiation at 254 nm and 365 nm wavelengths removes these hydrocarbon contaminants via photocatalytic decomposition, restoring and even enhancing surface hydrophilicity without chemical storage in saline solution.
Research by Ogawa et al. has extensively characterized UV photofunctionalization, demonstrating significantly increased protein adsorption, osteoblast migration, and BIC values in animal models. Xpeed applies this concept as a manufacturing-level treatment, producing a superhydrophilic surface with contact angles approaching 0° that is stable under sealed packaging conditions.
OsseoSpeed — Fluoride-Modified Surface (Dentsply Astra)
Dentsply Astra's OsseoSpeed surface combines a titanium fluoride (TiF₄) chemical modification with a blasted and etched topography. The incorporated fluoride ions are gradually released at the implant-bone interface during the early healing phase and are thought to stimulate osteoblast differentiation and bone mineralization through interaction with calcium-dependent cellular signaling pathways. The surface exhibits moderate hydrophilicity and a characteristically blue-violet appearance due to the fluoride-containing oxide layer.
Clinical studies for OsseoSpeed, particularly in combination with the Astra Tech OsseoSpeed EV implant system, have documented high survival rates and favorable marginal bone level stability over 5-year observation periods, with particular strength in posterior mandibular placement scenarios.
Comparative Overview
| Surface | Brand | Method | Wettability | Ra (approx.) | Healing Protocol | Immediate Loading |
|---|---|---|---|---|---|---|
| SLA | Straumann | Blast + acid etch | Hydrophobic | ~4 µm | 6–8 weeks | Limited |
| SLActive | Straumann | SLA + saline storage | Superhydrophilic | ~4 µm | 3–4 weeks | Well documented |
| Acqua | Neodent | Blast + etch + hydrophilization | Hydrophilic | ~3.5 µm | 3–4 weeks | Supported |
| NeoPoros | Neodent | Blast + etch + nano treatment | Hydrophilic | ~3.5 µm | 4–6 weeks | Conditional |
| TiUnite | Nobel Biocare | Anodization (micro-arc oxide) | Moderate | ~3–4 µm porous | 4–6 weeks | Conditional |
| Xpeed | MegaGen | Blast + etch + UV activation | Superhydrophilic | ~3 µm | 3–4 weeks | Supported |
| OsseoSpeed | Dentsply Astra | Blast + etch + fluoride | Moderate | ~3–4 µm | 4–6 weeks | Conditional |
Clinical Recommendations by Scenario
Compromised Bone Density (D3–D4)
In patients with low bone density — commonly encountered in the posterior maxilla, in patients with metabolic conditions, or in cases with a history of corticosteroid use — the early biological response to the implant surface is the limiting factor for achieving adequate primary stability maintenance during healing. SLActive and Acqua are the surfaces with the strongest evidence base for compromised bone scenarios. Their superhydrophilic character accelerates early BIC values, compensating partially for the lower mechanical primary stability achievable in soft bone. When placing implants in D3–D4 bone with these surfaces, a 4-week loading protocol is clinically defensible when ISQ values are ≥60 at placement and ≥70 at loading confirmation.
Immediate and Early Loading Protocols
For cases where immediate or early loading is planned (All-on-4, immediate single-tooth replacement, same-day provisionals), SLActive and Acqua are the preferred surface selections. Their accelerated osseointegration kinetics provide a larger biological safety margin during the period when the implant is simultaneously subjected to occlusal loading and undergoing primary osseointegration. Multiple systematic reviews and meta-analyses have documented that hydrophilic surfaces consistently outperform hydrophobic surfaces in early-loading scenarios across diverse patient populations.
Standard Cases with Adequate Bone
In straightforward cases with D1–D2 bone density, adequate volume, and conventional loading protocols, all of the surfaces reviewed — SLA, SLActive, Acqua, NeoPoros, TiUnite, Xpeed, and OsseoSpeed — deliver clinically equivalent long-term outcomes. The choice in this scenario shifts to factors beyond surface biology: implant geometry, connection type, prosthetic ecosystem, price, and clinical familiarity. Survival rates of 97–99% over 5 years are consistently reported across all major surface technologies when placed by experienced clinicians in favorable bone.
High-Risk Patients (Smokers, Diabetics, Irradiated Bone)
For patients who smoke, have poorly controlled diabetes (HbA1c >7.5%), or have received radiation to the jaw, the physiological impairment of the wound healing cascade makes surface wettability and early biological integration even more critical. Available evidence — while not as extensive as for standard patients — supports the use of SLActive and Acqua in these populations, with clinical guidance recommending extended healing periods of 4–6 months before final loading regardless of surface type.
For any case involving compromised bone density, immediate loading, or medically compromised patients: specify SLActive (Straumann) or Acqua (Neodent) surfaces. The accelerated osseointegration kinetics of hydrophilic surfaces provide a meaningful clinical buffer that translates directly into predictability and reduced complication rates.